Munich Imaging

03/02/2026

Wir testen einen neuen, nicht-invasiven Blutzuckersensor. In unserer Studie prüfen wir, ob unsere neue Methode den Blutzucker genauso misst wie etablierte Verfahren.

Ihre Vorteile:
• 100 Euro Aufwandsentschädigung
• Kostenfreie medizinische Basisuntersuchungen (z. B. Körperzusammensetzung, Blutanalyse)

Wer?
• Typ-2-Diabetes (nicht insulinpflichtig)
• BMI 18–29,9 (kg/m²)
• 18–70 Jahre
Wo?
• Olympiacampus München (TU München)
Interesse? Schreiben Sie an anna.reik@tum.de oder rufen Sie an: +49 89 289 249 63.

27/01/2026

Wir suchen noch Teilnehmer:innen mit Typ-2-Diabetes!

Im Rahmen des GLUMON-Projekts möchten wir eine neuartige nicht-invasive Technik zur Blutzuckermessung mit etablierten Verfahren vergleichen.

Wir freuen uns über alle, die mithelfen möchten, die Versorgung von Menschen mit Typ-2-Diabetes weiter zu verbessern!
​
Vielen Dank fürs Weiterleiten und Teilen!

After the first measurements in healthy volunteers (👉 https://www.medrxiv.org/content/10.1101/2025.03.12.25323511v1), the GLUMON Consortium moves forward with recruiting patients with type-2 diabetes or severe overweight.

🔗 For more information, check our website: https://glumon.munichimaging.eu/2025/12/12/partner-tum-is-now-recruiting/

Or scan the QR-Code below 😉

----

Nach den ersten Messungen an gesunden freiwilligen Probanden (👉 https://www.medrxiv.org/content/10.1101/2025.03.12.25323511v1) geht das GLUMON-Konsortium nun den nächsten Schritt und beginnt mit der Rekrutierung von Patienten mit Typ-2-Diabetes oder starkem Übergewicht.

🔗 Weitere Informationen finden Sie auf unserer Website: https://glumon.munichimaging.eu/2025/12/12/partner-tum-is-now-recruiting/

Oder scannen Sie den QR-Code unten 😉

16/01/2026

After the first measurements in healthy volunteers (👉 https://www.medrxiv.org/content/10.1101/2025.03.12.25323511v1), the GLUMON Consortium moves forward with recruiting patients with type-2 diabetes or severe overweight.

🔗 For more information, check our website: https://glumon.munichimaging.eu/2025/12/12/partner-tum-is-now-recruiting/

Or scan the QR-Code below 😉

----

Nach den ersten Messungen an gesunden freiwilligen Probanden (👉 https://www.medrxiv.org/content/10.1101/2025.03.12.25323511v1) geht das GLUMON-Konsortium nun den nächsten Schritt und beginnt mit der Rekrutierung von Patienten mit Typ-2-Diabetes oder starkem Übergewicht.

🔗 Weitere Informationen finden Sie auf unserer Website: https://glumon.munichimaging.eu/2025/12/12/partner-tum-is-now-recruiting/

Oder scannen Sie den QR-Code unten 😉

12/12/2025

📢 Job alert! 📢

The science management team provides comprehensive administrative support to our researchers, giving them room to focus their full creative potential on developing the imaging and sensing technology of tomorrow.

🔍 We now seek a highly qualified and motivated Science Manager (f/m/d) to support our ongoing third-party projects and the preparation of new grant applications.

🔗 Check the full description here: https://portal.mytum.de/jobs/wissenschaftler/NewsArticle_20250526_132103/

14/11/2025

At , we’re pushing the boundaries of care.

🚀 We’re advancing data-driven diabetes research by combining and with multi-omics data and AI to uncover the molecular and physiological mechanisms underlying the disease.

👉 focuses on multivariate, long-term tracking of diabetes progression by capturing a spectrum of biomarkers related to tissue metabolism, oxygenation, and microvascular health.
👉 pioneers non-invasive glucose monitoring, using in-vivo optoacoustic sensing to measure blood glucose dynamics directly and pain-free.
👉 combines optoacoustic imaging phenotypes with multi-omics data (genomics, proteomics, metabolomics) and AI to build a digital-twin model for early detection, prevention and treatment of type 2 diabetes.

🔗 Learn more:
https://mosaic.munichimaging.eu/
https://glumon.munichimaging.eu/
https://optomics.munichimaging.eu/

21/10/2025

𝐍𝐞𝐫𝐯𝐞𝐬 - the electrical cables of our body.
Thanks to them, we can move our muscles and perceive the world around us.

But have you ever wondered 𝐰𝐡𝐚𝐭 𝐭𝐡𝐞𝐲 𝐥𝐨𝐨𝐤 𝐥𝐢𝐤𝐞?
Or better yet — 𝐡𝐨𝐰 𝐭𝐡𝐞𝐲 𝐬𝐨𝐮𝐧𝐝 𝐰𝐡𝐞𝐧 𝐢𝐥𝐥𝐮𝐦𝐢𝐧𝐚𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐥𝐢𝐠𝐡𝐭?

In our lab, we are using 𝐨𝐩𝐭𝐨𝐚𝐜𝐨𝐮𝐬𝐭𝐢𝐜 𝐢𝐦𝐚𝐠𝐢𝐧𝐠 to explore exactly that.
This 𝐧𝐨𝐧-𝐢𝐧𝐯𝐚𝐬𝐢𝐯𝐞 and 𝐩𝐚𝐢𝐧-𝐟𝐫𝐞𝐞 technology combines light and sound to visualize nerves in ways never seen (or heard!) before.

We are currently looking for 𝐡𝐞𝐚𝐥𝐭𝐡𝐲 𝐯𝐨𝐥𝐮𝐧𝐭𝐞𝐞𝐫𝐬 to join our clinical study at 𝐊𝐥𝐢𝐧𝐢𝐤𝐮𝐦 𝐑𝐞𝐜𝐡𝐭𝐬 𝐝𝐞𝐫 𝐈𝐬𝐚𝐫 (Munich, Germany) and help us advance the future of nerve imaging.

Do you want to be part of our study or are you curious to learn more?
Do not hesitate to reach out to us at 𝐧𝐞𝐫𝐯𝐞.𝐦𝐬𝐨𝐭.𝐜𝐛𝐢@𝐦𝐡.𝐭𝐮𝐦.𝐝𝐞.
We will be happy to provide you with more details and, if you are interested, schedule an appointment at a time that best suits you!

Looking forward to seeing you!

20/10/2025

👉 Following on our series of events, from October 10th - 12th, the MunichImaging team was part of the Helmholtz Munich booth at the Münchner Wissenschaftstage .

👩‍👩‍👦 The event took place at the Forum Schwanthalerhöhe and atracted thousands of people over the 3 days - specially children and families.

👨‍🔬 Representing the , we prepared a lot of fun activities for our visitors: a cool Twister game, demonstrations of and , the opportunity to be a scientist for a few moments, and even to write a secret letter with magic UV-pens! ✨

It was also an amazing opportunity to showcase our EU-funded projects, present main results to the public, and discuss the current challenges in healthcare.

This was our third consecutive participation at the event, and we're looking forward for the 2026 edition! 🚀

20/10/2025

Last week was really busy at MunichImaging!

Starting on October 9th - 10th, part of our team joined the Helmholtz Munich booth on the herCAREER - Europe’s leading career and networking platform for women!

It was a great opportunity to connect with inspiring people!

05/09/2025

If you are attending the NanoBio Conference next week in Heraklion, make sure not to miss the PlenaryTalk "Listening to light: Advances in optoacoustic imaging", from MunichImaging director Prof. Vasilis Ntziachristos.

📍 Heraklion, Crete
📅 Tuesday, 09.09.2025
⏰ 13:15 - 14:00 (Greek time)

🔗 For more information: https://nanobioconf.com/

19/08/2025

If you attend the meeting of the International Society on Oxygen Transport to Tissue ( ) in Thessaloniki, Greece, mark your calendar for the plenary by Munich Imaging director Vasilis Ntziachristos on “ imaging of transport in tissues.”
25 Aug 2025, 8:30-9:30 am (Greek time)
https://isott2025.com/index.php/invited-speakers-2/

12/08/2025

Munich Imaging compared bulk and opto-mechanical micromachined detectors (OMUS) for and – with OMUS bearing potential as a low-cost alternative.
Read the article in SENSORS :
https://ieeexplore.ieee.org/document/11121568

06/08/2025

Our year-long joint efforts in the consortium come to a wonderful - almost - end with this publication on the hybrid for the early detection of in Nature Magazine Biomedical Engineering.

Looking back at the hard work the whole consortium put into the development of this 360° spinning capsule and the backend system, we want to thank all partners!

With these promising results at hand, the story MUST continue... and it does:

We will further advance the hybrid endoscope incorporating in-vivo and within the new project ESOHISTO - hybrid endoscope for ESOphageal in vivo HISTOlogy and histochemistry

👉 Read more: https://www.helmholtz-munich.de/en/newsroom/news-all/artikel/new-endoscopy-technology-enables-early-detection-of-esophageal-cancer

🔗 To the original publication: https://www.nature.com/articles/s41551-025-01462-0

We want to express our gratitude to the consortium of ESOTRAC:

Helmholtz Munich

Medical University of Vienna

Statice

University of Cambridge

RayFos Ltd.

SONAXIS

Ascenion GmbH

DTU - Technical University of Denmark

Amplitude Laser

And to our sponsors:
European Commission

A high-resolution three-dimensional endoscopic imaging technique resolves unique features in Barrett’s oesophageal neoplasia.